Sputnik V developer the Gamaleya Institute in Moscow, Russia’s first vaccine against COVID-19 on Wednesday announced that no longer placebos to the volunteers in its vaccine final-stage trials. At present, the vaccine is now undergoing large-scale trials in the final stage to ascertain the safety imbued in the vaccine - which was considered as the world’s first COVID-19 vaccine by Russian authorities.
A few months ago, country reported that the vaccine was being given to top players in Russian administration, including President Putin’s daughter. Russian news agency reported that placebos will no longer be part of the trial. In every vaccine trial, placebos are used to ensure no false results are logged. Alexander Ginsburg, the director of Gamaleya Institute said that the Health Ministry has officially ended the usage of placebos on the recruits for the most crucial and the final stages of trials.
"Everything there has been proven and the pandemic is ongoing, so a placebo is not good at all," Ginsburg said, as reported by Russian agency. Russia rolled out the Sputnik V vaccine for healthcare workers among others on the frontline of fighting the virus in the beginning of December. Russia had received criticism for approving the vaccine after less than two months of human testing August. But data claims that the vaccine is 91.4 per cent effective in fighting COVID-19.
Sputnik V Developers assure almost 2 years immunity against Covid 19
Russia's Sputnik V developers ready to share technology with Sanofi, GSK